| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
39
|
318 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
21
|
47 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
18
|
42 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
15
|
27 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
14
|
16 |
| IL12A-AS1 |
|
IL12A antisense RNA 1
|
|
|
0.633 |
0.654 |
12
|
32 |
| PPT2-EGFL8 |
|
PPT2-EGFL8 readthrough (NMD candidate)
|
|
|
0.792 |
0.462 |
9
|
10 |
| TH2LCRR |
|
T helper type 2 locus control region associated RNA
|
|
|
0.751 |
0.385 |
9
|
8 |
| HCG22 |
E2RYF7
|
HLA complex group 22 (gene/pseudogene)
|
|
|
0.736 |
0.423 |
9
|
11 |
| USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
7
|
7 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
7
|
4 |
| LINC02649 |
|
long intergenic non-protein coding RNA 2649
|
|
|
0.792 |
0.308 |
6
|
3 |
| SNORA38 |
|
small nucleolar RNA, H/ACA box 38
|
|
|
0.890 |
0.154 |
6
|
2 |
| NONOP2 |
|
non-POU domain containing, octamer-binding pseudogene 2
|
|
|
0.861 |
0.231 |
5
|
2 |
| WTAPP1 |
|
Wilms tumor 1 associated protein pseudogene 1
|
|
|
0.890 |
0.154 |
5
|
3 |
| LINC01934 |
|
long intergenic non-protein coding RNA 1934
|
|
|
0.821 |
0.308 |
5
|
2 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
5
|
8 |
| MROH3P |
|
maestro heat like repeat family member 3, pseudogene
|
|
|
0.890 |
0.192 |
5
|
2 |
| LINC02471 |
|
long intergenic non-protein coding RNA 2471
|
|
|
0.861 |
0.154 |
4
|
3 |
| LRRK2-DT |
|
LRRK2 divergent transcript
|
|
|
0.861 |
0.154 |
4
|
3 |
| IRGM |
A1A4Y4
|
immunity related GTPase M
|
|
|
0.617 |
0.538 |
4
|
4 |
| LINC02656 |
|
long intergenic non-protein coding RNA 2656
|
|
|
0.931 |
0.154 |
4
|
2 |
| IFNG-AS1 |
|
IFNG antisense RNA 1
|
|
|
0.659 |
0.654 |
3
|
3 |
| LINC02357 |
|
long intergenic non-protein coding RNA 2357
|
|
|
0.805 |
0.231 |
3
|
4 |